Arm Holdings issues disappointing guidance, Nvidia rises as the Trump administration plans to scrap Biden’s chip-export rules ...

At the new $5.69 annual rate and its current share price, PepsiCo's stock has a 4.3% dividend yield. That's more than three ...

Foreign investors have been turning to Australia's domestically focused stocks, choosing an often overlooked market as a ...

The Dow, S&P 500 and Nasdaq futures were all rising Thursday on trade deal hopes. Bitcoin prices are up and the U.S. dollar ...

The gains began early after reports that Treasury Secretary Scott Bessent and U.S. Trade Representative Jamieson Greer will ...

The stock market might have seen some gains since Trump's tariff war started, but has it been enough. Here's how the stock ...

U.S. stocks advanced on Wednesday in choppy trading, buoyed as semiconductor stocks rallied late on a report that regulations ...

U.S. stocks are sinking as more companies scrub their forecasts for upcoming profits because of uncertainty created by ...

The S&P 500 Utilities Select ETF ( XLU) is up more than 6% compared to a 4% drop for the broad-based index, an 8% drop for ...

Zepbound is the preferred weight loss medicine vs. Wegovy and has consistently beaten the latter in U.S. weekly prescriptions ...

Uncertainty on Wall Street is at its highest level in years, but you wouldn't have known it watching the stock market last ...

Its biggest would-be competitor is ivonescimab, a medicine being developed in the U.S. by Summit Therapeutics. It delivered positive clinical trial results in China in a phase 3 study in which it went ...